Skip to content

Harvard Scientists Breakthrough Antibiotic Resistance with Synthetic Superbug Slayer

Harvard Scientists Antibiotic Breakthrough 2-28-24

An agar plate containing colonies of Klebsiella pneumoniae bacteria, one of the drug-resistant strains the synthetic compound cresomycin has shown to combat. Credit: Myers Research Group

“Funding and other support from groups like the Blavatnik Biomedical Accelerator and CARB-X are essential for the discovery and development of new antibiotics,” said Curtis Keith, the Harvard accelerator’s chief scientific officer.

Back to News

Learn More

Discover the cutting-edge science we fund

Providing many of the world's best researchers, scientists, and universities with support, and funding to discover breakthroughs that solve humankind's greatest challenges.

See how we support great cultural institutions around the world

The Foundation contributes to renowned institutions that showcase the breadth of arts and culture, including performance, exhibition and education.

Visit the Blavatnik Archive

The Blavatnik Archive is a nonprofit foundation dedicated to preserving and disseminating materials that contribute to the study of 20th-century Jewish and world history, with a special emphasis on World War I, World War II, and Soviet Russia.